{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:24:12Z","timestamp":1767979452333,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T00:00:00Z","timestamp":1395014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0091746","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T20:42:12Z","timestamp":1395088932000},"page":"e91746","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Palliation of Bone Cancer Pain by Antagonists of Platelet-Activating Factor Receptors"],"prefix":"10.1371","volume":"9","author":[{"given":"Katsuya","family":"Morita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyo","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Uezono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,17]]},"reference":[{"key":"ref1","volume":"2","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer <volume>2<\/volume>: : 584\u2013593."},{"key":"ref2","volume":"353","unstructured":"Portenoy RK, Lesage P (1999) Management of cancer pain. Lancet <volume>353<\/volume>: : 1695\u20131700."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(00)00455-3","article-title":"The amsterdam pain management index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain","volume":"91","author":"R de Wit","year":"2001","journal-title":"Pain"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pain.2004.07.016","article-title":"Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice","volume":"111","author":"K Morita","year":"2004","journal-title":"Pain"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pain.2008.01.030","article-title":"Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate-NO-cyclic GMP signalling in spinal cord in mice","volume":"138","author":"K Morita","year":"2008","journal-title":"Pain"},{"key":"ref6","volume":"5","unstructured":"Hasegawa S, Kohro Y, Shiratori M, Ishii S, Shimizu T, <etal>et al<\/etal>.. (2010) Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One <volume>5<\/volume> , e10467."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-8-8","article-title":"Up-regulation of Platelet-activating factor synthases and its receptor in spinal cord contribute to development of neuropathic pain following peripheral nerve injury","volume":"8","author":"M Okubo","year":"2012","journal-title":"Mol Pain"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/j.1532-2149.2013.00289.x","article-title":"Pain-releasing action of Platelet-activating factor (PAF) antagonists in neuropathic pain animal models and the mechanisms of action","volume":"17","author":"N Motoyama","year":"2013","journal-title":"Eur J Pain"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1526-4637.2000.00047.x","article-title":"Bone cancer pain: from mechanism to model to therapy","volume":"1","author":"P Honore","year":"2000","journal-title":"Pain Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0304-3959(02)00102-1","article-title":"Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain","volume":"99","author":"NM Luger","year":"2002","journal-title":"Pain"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-3959(94)00183-F","article-title":"Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E<sub>2<\/sub> or prostaglandin F<sub>2\u03b1<\/sub> in conscious mice","volume":"61","author":"T Minami","year":"1995","journal-title":"Pain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1744-8069-6-38","article-title":"Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord","volume":"6","author":"Y Yanagisawa","year":"2010","journal-title":"Mol Pain"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(99)00006-8","article-title":"Breakthrough pain: characteristics and impact in patients with cancer pain","volume":"81","author":"RK Portenoy","year":"1999","journal-title":"Pain"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000048379","article-title":"The significance of intrathecal opioid therapy for the treatment of neuropathic cancer pain conditions","volume":"75","author":"R Becker","year":"2000","journal-title":"Stereotact Funct Neurosug"},{"key":"ref15","unstructured":"Li X, Wang X-W, Feng X-M, Zhou W-J, Wang Y-Q, <etal>et al<\/etal>.. (2013) Stage-dependent anti-allodynia effects of intrathecal Toll-like receptor 4 antagonists in a rat model of cancer induced bone pain. J Physiol Sci DOI 10.1007\/s12576-D12-0244-5."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1172\/JCI118142","article-title":"Platelet-activating factor produced in vitro by Kaposi&apos;s Sarcoma cells induces and Sustains in vivo angiogenesis","volume":"96","author":"F Bussolino","year":"1995","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0002-9440(10)64808-0","article-title":"PAF produced by human brest cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis","volume":"157","author":"B Bussolati","year":"2000","journal-title":"Am J Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.10545","article-title":"Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis","volume":"100","author":"B Bussolati","year":"2002","journal-title":"Int J Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0090-6980(02)00109-0","article-title":"Synthesis of platelet-activating factor (PAF) in transformed cell lines of a different origin","volume":"70","author":"A Fallani","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2174\/187152609788922555","article-title":"The implication of platelet-activating factor in cancer growth and metastasis: Potent beneficial role of PAF-inhibitors and antioxidants","volume":"9","author":"AB Tsoupras","year":"2009","journal-title":"Infectious Disorders-Drug Targets"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0022-3565(25)11360-8","article-title":"Beneficial effects of TCV-309, a novel potent and selective platelet-activating factor antagonist in endotoxin and anaphylaxis shock in rodents","volume":"260","author":"Z-I Terashita","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.npp.1301471","article-title":"Comparative Pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine","volume":"33","author":"M Narita","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1254\/jphs.09139FP","article-title":"Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models","volume":"111","author":"K Minami","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.2012.02139.x","article-title":"Differential activation of the \u03bc-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model","volume":"168","author":"A Nakamura","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Yuan C-S (2005) Handbook of opioid bowel syndrome. New York: Haworth Medical Press: Haworth Reference Press. 256 p.","DOI":"10.1201\/9781482289633"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(98)00071-4","article-title":"Endogenous opioids: overview and current issues","volume":"51","author":"H Akil","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00115550-200011000-00016","article-title":"Antagonism of gastrointestinal opioid effects","volume":"25","author":"C-S Yuan","year":"2000","journal-title":"Reg Anesth Pain Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/oxfordjournals.jbchem.a003164","article-title":"Platelet\u2013activating factor receptor","volume":"131","author":"Z Honda","year":"2002","journal-title":"J Biochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/emboj\/16.1.133","article-title":"Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor","volume":"16","author":"S Ishii","year":"1997","journal-title":"EMBO J"},{"key":"ref30","first-page":"4777","article-title":"Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A","volume":"54","author":"M Maggi","year":"1994","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65488-0","article-title":"Motility induced by human immunodeficiency virus-1 Tat on Kaposi&apos;s sarcoma cells requires platelet-activating factor synthesis","volume":"155","author":"L Biancone","year":"1999","journal-title":"Am J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10555-007-9092-9","article-title":"Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor","volume":"26","author":"V Melnikova","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2407-10-200","article-title":"Platelet-activating factor receptor (PAF-R)-dependent pathways control tumor growth and tumor response to chemotherapy","volume":"10","author":"SI de Oliveira","year":"2010","journal-title":"BMC Cancer"},{"key":"ref34","first-page":"2662","article-title":"Augmentation of tumor metastases by platelet-activating factor","volume":"56","author":"SY Im","year":"1996","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00000658-199305010-00004","article-title":"Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial","volume":"217","author":"KD Lillemoe","year":"1993","journal-title":"Annals Surgery"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2009.03.018","article-title":"Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain","volume":"123","author":"T Dohi","year":"2009","journal-title":"Pharmacol Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0091746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:29:49Z","timestamp":1746152989000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0091746"}},"subtitle":[],"editor":[{"given":"Theodore John","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,17]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0091746","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,17]]}}}